ArticleCurrent infectious disease reports2014
Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients.
Article in Current infectious disease reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 45 citations in OpenAlex.
- Management of Antiretroviral Therapy and Opportunistic Infections in People Living with HIV Undergoing Hematopoietic Stem Cell Transplant in British Columbia.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2024Article
- Differences in plasma proteomes for active tuberculosis, latent tuberculosis and non-tuberculosis mycobacterial lung disease patients with and without ESAT-6/CFP10 stimulation.Proteome science · 2020Article
- An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients.Paediatric drugs · 2018Review
- Disseminated Mycobacterium haemophilum infection in a renal transplant recipient.BMJ case reports · 2016Article
- Nontuberculous mycobacteria infections in immunosuppressed hosts.Clinics in chest medicine · 2015Review
- Specific Proteins in Nontuberculous Mycobacteria: New Potential Tools.BioMed research international · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nontuberculous mycobacteria (NTM) are recognized as emerging pathogens. NTM disease in transplant recipients remains a diagnostic and therapeutic challenge. Herein, a review of the most recent literature will provide an update in regard to the epidemiology, clinical presentation, diagnosis, treatment, and prevention of NTM disease in solid organ and hematopoietic stem cell transplant recipients. Special consideration will be given to the lung transplant population.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.